Abstract:Abstract Background There are over 16.8 million rare disease patients in China, representing a large community that should not be neglected. While the public lack the awareness of their existence and difficult status quo, for one reason that they exist as a rare and special group in our society, for another reason that all sectors of the community haven’t introduced and propagandized them suitably. However, as a special group with more difficulties in all aspects than normal healthy persons, they need enough care and love from us. To provide a basis for policy-makers to better understand the status quo of rare disease patients and care-givers in China and to devise some new policies to improve their quality of life, a comprehensive analysis of the status quo, unmet needs, difficulty caused by the rare disease is essential. Methods A questionnaire-based online study of patients and care-givers (usually family members) was performed. The questionnaire was composed of 116 questions, such as the diagnosis process, treatment access, financial burden, views on patients’ organizations, and a series of standardized tests to assess the quality of their life, including the SF-36, PHQ-9, PHQ-15, GAD-7, and PSQI. To examine the influence of age, disease type, and relationship to patients on the scores in these tests, statistical analysis with a general linear model was conducted. Findings A total of 1959 patients and care-givers participated in the survey, representing 104 rare diseases, such as lysosomal storage diseases, hemophilia, and muscular dystrophy diseases. The diagnosis was delayed for 1.4 ± 3.0 years, and patients experienced 1.6 ± 3.8 misdiagnoses between 3.2 ± 2.4 hospitals. The hospitals where diagnoses were made were highly concentrated in 10 large hospitals (43.8%) and 5 big cities (42.1%), indicating a significant inequality of medical resources. The disease often led to difficulty in social life, education, and employment, as well as financial burden that was seldom covered by medical insurance. A battery of standardized tests demonstrated poor health status, depression, somatization, anxiety, and sleeping issues among both patients and care-givers ( p < 0.05). Statistical analysis of the questionnaire also showed that poor health, anxiety, depression, somatization, and sleeping problems were more prevalent in patients than in care-givers, and more prevalent in more severe diseases (e.g., hemophilia, Dravet) or undiagnosed than in other diseases. Interpretations This study identified the lack of rare disease awareness and legislative support as the major challenge to rare diseases in China, and makes key recommendations for policy-makers, including legislating orphan drug act, raising rare disease awareness, providing sufficient and fair opportunities about education and employment, expanding the medical insurance coverage of treatments, and protecting rights in education and employment.

Rare disease emerging as a global public health priority

Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges

Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis

Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study

Global Health for Rare Diseases Through Primary Care

Review of 11 national policies for rare diseases in the context of key patient needs

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

National Rare Diseases Registry System of China and Related Cohort Studies: Vision and Roadmap.

Innovative Measures To Combat Rare Diseases In China: The National Rare Diseases Registry System, Larger-Scale Clinical Cohort Studies, And Studies In Combination With Precision Medicine Research

Prevalence of Rare Diseases:The Health Crisis for an Extremely Vulnerable Population

Rare diseases: human genome research is coming home

National Rare Diseases Registry System (NRDRS): China’s first nation-wide rare diseases demographic analyses

Patterns of the Health and Economic Burden of 33 Rare Diseases in China: Nationwide Web-Based Study

A questionnaire-based study to comprehensively assess the status quo of rare disease patients and care-givers in China

Rare diseases in China: analysis of 2014–2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals

Rare disease genomics and precision medicine

Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China

Rare genetic diseases in India: Steps toward a nationwide mission program

Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Lessons from the Rare Diseases Registry and Analytics Platform framework for development of a national rare diseases registry for India